In contrast to previous studies, a recent study by Zhu and colleagues [112] reported that the upregulation of APOM stimulates cell proliferation, invasion, and tumor development in NSCLC by inducing sphingosine-1-phosphate, leading to the activation of the ERK1/2 and PI3K/AKT signaling pathways. The gene discussed is APOM; the disease is neoplasm.